Renata plc shipped 12.4 million tablets of metoprolol tartrate to the US market from its US-FDA approved factory in Rajendrapur, Gazipur (RGF). This marks the first direct supply from their own facility, breaking from their previous reliance on contract manufacturing. Metoprolol tartrate is utilized in treating various conditions like high blood pressure, angina, and heart failure. In 2021, the US witnessed 65.5 million prescriptions for this drug. Renata operates 16 factories across three locations, with RGF gaining US-FDA approval in November 2022. They’re actively developing 70 bio-equivalent products, facilitated by 160 domestic scientists, and exporting to 40 countries globally.
Source for more details:
